CD79A and nasopharyngeal carcinoma: In addition, elevated serum EBV capsid antigen (VCA) Immunoglobulin A (IgA) or EBV DNA titers are associated with an increased risk of developing NPC, with raised levels associated with advanced disease and observed to precede the clinical onset of NPC (4, 16).